Ghrp 2 vs Ipamorelin: Comparing the Indexed Record
Before Ghrp 2 and Ipamorelin can be compared on anything else, they have to be compared on evidence: what has actually been indexed, and where.
Compound profiles
Ghrp 2 in the indexed record
Searching Ghrp 2 against the PubMed index returns 204 records, a moderate evidence base, alongside 1 registered studies on ClinicalTrials.gov.
Publications carrying this compound include Drug Test Anal, Drugs R D, Eur J Endocrinol, spanning 1998–2015.
- Ipamorelin, the first selective growth hormone secretagogue — Eur J Endocrinol, 1998. PMID: 9849822
- Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN — Drugs R D, 2004. PMID: 15230633
- Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: growth hormone isoform profiles in Japanese male subjects — Drug Test Anal, 2010. PMID: 21249726
- GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin ligases, Atrogin-1 and MuRF1 — Life Sci, 2008. PMID: 18191156
Ipamorelin in the indexed record
The literature on Ipamorelin is a moderate body of work: 54 PubMed-indexed records, alongside 3 registered studies on ClinicalTrials.gov.
Publications carrying this compound include Am J Sports Med, Eur J Endocrinol, J Am Acad Orthop Surg Glob Res Rev, spanning 1998–2026.
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians — Am J Sports Med, 2026. PMID: 41476424
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions — J Am Acad Orthop Surg Glob Res Rev, 2026. PMID: 41490200
- Ipamorelin, the first selective growth hormone secretagogue — Eur J Endocrinol, 1998. PMID: 9849822
- A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review — J Sports Med Phys Fitness, 2026. PMID: 41880199
How the literature differs
The indexed record is not symmetrical between these two compounds. Ghrp 2 carries 150 more indexed records than Ipamorelin, which means published methodology, characterisation data and replication attempts are more readily located for Ghrp 2. For a researcher planning a literature review, that asymmetry usually determines which compound has established reference protocols and which requires primary-source work.
Registered study counts (1 vs 3) track a different signal — formal study registration rather than published output — and the two figures frequently diverge.
Side-by-side research profile
| Parameter | Ghrp 2 | Ipamorelin |
|---|---|---|
| PubMed indexed records | 204 | 54 |
| Registered studies (ClinicalTrials.gov) | 1 | 3 |
| Literature depth | Moderate | Moderate |
| Handling class | Lyophilised powder | Lyophilised powder |
| Designation | Research use only | Research use only |
Classification and why it matters
Ghrp 2 and Ipamorelin sit in different structural classes, and that classification is what determines whether a published protocol for one has any bearing on the other. Peptide research compounds are grouped by sequence length, origin and the receptor families the literature associates with them — not by the outcome a reader might be looking for.
Reading across classes is the most common error in a literature review. A protocol developed for Ghrp 2 describes conditions validated for Ghrp 2: concentration ranges, solvent choice, incubation windows and control selection were all established against that compound. Applying those same conditions to Ipamorelin without re-validation produces data that cannot be compared back to the source publication.
Where the two compounds are studied in overlapping models, the published work almost always treats them as separate arms rather than as substitutes. That separation is the useful signal: it indicates the research record does not consider them equivalent.
Documentation standards
Identity and purity are separate claims requiring separate methods. A purity percentage quoted without the analytical method behind it, or a certificate with no lot reference, is a documentation gap rather than verification.
Selecting between them for a study design
Ghrp 2 and Ipamorelin are not interchangeable. They differ in structural class and in the pathways the literature associates with each, so substituting one for the other changes what a model is actually measuring.
Where a protocol cites a specific compound, the cited compound is the one the published result applies to. Where no protocol exists, the compound with the deeper indexed record (Ghrp 2) generally offers more methodological precedent.
Frequently asked questions
Which of Ghrp 2 or Ipamorelin has more published research?
Ghrp 2, with 204 indexed PubMed records against 54.
What is the regulatory status of these compounds?
Neither is an approved drug. Both are supplied strictly for in-vitro laboratory research and are not intended for human or veterinary consumption.
How should these compounds be stored?
Lyophilised material is conventionally stored at -20°C protected from light. Reconstituted solution is far less stable and is held at 2-8°C for short-duration laboratory work only.
Are Ghrp 2 and Ipamorelin the same compound?
No. They are structurally distinct research compounds with separate literature records — 204 indexed records for Ghrp 2 and 54 for Ipamorelin.
Related references
- Ipamorelin — product and lot documentation
- Certificate of analysis & purity testing
- Research reference index
Research use only. The compounds discussed are supplied for in-vitro laboratory research. They are not drugs, are not approved for the diagnosis, treatment, cure or prevention of any condition, and are not intended for human or veterinary consumption.